nacfc 2022 | w31: airway physiology directed therapies
Published 1 year ago • 72 plays • Length 1:54:30Download video MP4
Download video MP3
Similar videos
-
1:47:02
nacfc 2023 | w10: airway physiology directed therapies
-
1:28:24
nacfc 2021 | w31: difficult to treat cftr mutations, novel modulator, rna editing tech to fix cftr
-
1:02:36
cf foundation | nacfc 2022 highlights
-
1:52:31
nacfc 2022 | s01: design of clinical trials to evaluate nucleotide-based interventions
-
1:58:25
nacfc 2022 | s31: stronger together: updates from international clinical trials
-
1:57:14
nacfc 2022 | w36: genetic and cell-based approaches to cystic fibrosis therapy
-
1:52:14
nacfc 2022 | dg03: insights to the unique needs of cystic fibrosis across the lifespan
-
1:57:41
nacfc 2022 | s03: are cftr modulators reducing airway infection and inflammation?
-
1:41:06
nacfc 2022 | w16: updates in cystic fibrosis pharmacotherapy
-
1:43:28
nacfc 2022 | w32: airway ions, fluids, and mucus transport
-
1:51:16
nacfc 2021 | w29: therapies beyond cftr
-
2:00:19
nacfc 2022 | s13: progress towards genomic correction of cystic fibrosis lung disease
-
1:32:04
nacfc 2022 | w04: emerging topics in cftr cellular biology
-
1:18:08
nacfc 2020 | s24: leveraging lung biology: gateway to therapy for all
-
55:30
nacfc 2018 | plenary 2: anti-inflammatories and mucociliary clearance therapies